Benefit-risk assessment is essential to demonstrate the clinical and economic value of a treatment to HTA bodies, payers, and regulators.
One2Treat Insights is a quantitative benefit-risk platform that integrates efficacy, safety, and patient-reported outcomes into a single, transparent framework to support evidence-based decision-making.
One2Treat Insights enables consistent, data-driven benefit-risk assessment across all clinically relevant outcomes, helping teams build a strong case for reimbursement, pricing, and commercialization.
- Perform benefit-risk assessment across efficacy, safety, and patient-reported outcomes in a unified framework
- Generate quantitative evidence to support HTA submissions and pricing negotiations
- Incorporate patient preferences and outcomes to strengthen value demonstration
- Identify and communicate trade-offs between benefits and risks with clarity and transparency
Traditional assessments often rely on isolated endpoints, limiting the ability to fully characterize treatment value.
One2Treat Insights addresses this by leveraging the totality of the evidence, integrating all relevant clinical outcomes and their interactions into a single analysis. This enables a more comprehensive and realistic evaluation of benefit-risk, aligned with the expectations of HTA bodies and market access stakeholders.
This approach enables a clear quantification of the Net Treatment Benefit, providing a consistent metric to compare treatments and support value-based decision-making across development and commercialization stages.
From early evidence generation to market access strategy, One2Treat Insights provides the analytical foundation to demonstrate treatment value with clarity and credibility.
